1. Chu, Bo, Kon, Ning, Chen, Delin, Tavana, Omid, Gu, Wei. 2019. ALOX12 is required for p53-mediated tumour suppression through a distinct ferroptosis pathway. In Nature cell biology, 21, 579-591. doi:10.1038/s41556-019-0305-6. https://pubmed.ncbi.nlm.nih.gov/30962574/
2. Ke, Hanni, Tang, Shuyan, Guo, Ting, Jin, Li, Chen, Zi-Jiang. 2023. Landscape of pathogenic mutations in premature ovarian insufficiency. In Nature medicine, 29, 483-492. doi:10.1038/s41591-022-02194-3. https://pubmed.ncbi.nlm.nih.gov/36732629/
3. Zhang, Xiao-Jing, She, Zhi-Gang, Wang, Junyong, Wang, Yibin, Li, Hongliang. 2021. Multiple omics study identifies an interspecies conserved driver for nonalcoholic steatohepatitis. In Science translational medicine, 13, eabg8117. doi:10.1126/scitranslmed.abg8117. https://pubmed.ncbi.nlm.nih.gov/34910546/
4. Al-E-Ahmad, Atiyeh, Parsian, Hadi, Fathi, Mojtaba, Nooreddini, Haji Ghorban, Mosapour, Abbas. . ALOX12 gene polymorphisms and serum selenium status in elderly osteoporotic patients. In Advances in clinical and experimental medicine : official organ Wroclaw Medical University, 27, 1717-1722. doi:10.17219/acem/75689. https://pubmed.ncbi.nlm.nih.gov/30277667/
5. Witola, William H, Liu, Susan Ruosu, Montpetit, Alexandre, Muench, Stephen P, McLeod, Rima. 2014. ALOX12 in human toxoplasmosis. In Infection and immunity, 82, 2670-9. doi:10.1128/IAI.01505-13. https://pubmed.ncbi.nlm.nih.gov/24686056/
6. Wang, Meixi, Wang, Jingjing, Wang, Jinni, Wu, Yonggui, Qi, Xiangming. 2024. Elevated ALOX12 in renal tissue predicts progression in diabetic kidney disease. In Renal failure, 46, 2313182. doi:10.1080/0886022X.2024.2313182. https://pubmed.ncbi.nlm.nih.gov/38345057/
7. Harsløf, T, Husted, L B, Nyegaard, M, Rejnmark, L, Langdahl, B L. 2010. Polymorphisms in the ALOX12 gene and osteoporosis. In Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 22, 2249-59. doi:10.1007/s00198-010-1472-2. https://pubmed.ncbi.nlm.nih.gov/21104233/
8. Matsumoto, Taichi, Murakami, Yuichi, Yoshida-Sakai, Nao, Ono, Mayumi, Kuwano, Michihiko. 2024. Enhanced ALOX12 Gene Expression Predicts Therapeutic Susceptibility to 5-Azacytidine in Patients with Myelodysplastic Syndromes. In International journal of molecular sciences, 25, . doi:10.3390/ijms25094583. https://pubmed.ncbi.nlm.nih.gov/38731802/
9. Berthelot, Claire C, Kamita, Shizuo George, Sacchi, Romina, Hammock, Bruce D, Zivkovic, Angela M. 2015. Changes in PTGS1 and ALOX12 Gene Expression in Peripheral Blood Mononuclear Cells Are Associated with Changes in Arachidonic Acid, Oxylipins, and Oxylipin/Fatty Acid Ratios in Response to Omega-3 Fatty Acid Supplementation. In PloS one, 10, e0144996. doi:10.1371/journal.pone.0144996. https://pubmed.ncbi.nlm.nih.gov/26672987/